Apollo Capital Urges Shareholders to Vote Gold Proxy Card for New Board, Disregard MediPharm's Green Proxy Ahead of Upcoming Shareholders Meeting

Reuters
05-21
Apollo Capital Urges Shareholders to Vote Gold Proxy Card for New Board, Disregard MediPharm's Green Proxy Ahead of Upcoming Shareholders Meeting

Apollo Technology Capital Corporation, a significant shareholder of MediPharm Labs Corp., has issued voting recommendations ahead of the company's 2025 Annual and Special Meeting of Shareholders scheduled for June 16. Apollo Capital, owning approximately 3.0% of MediPharm's common stock, urges shareholders to disregard MediPharm's green proxy card and instead vote for the gold proxy card in support of Apollo Capital's six director nominees. These nominees-John Fowler, Alan D. Lewis, David Lontini, Demetrios Mallios, Regan McGee, and Scott Walters-are presented as highly qualified candidates capable of addressing issues such as strategic failures and excessive executive compensation at MediPharm. Apollo Capital has launched a campaign website, CureMediPharm.com, to outline their five-pillar plan aimed at restoring value and accountability to the company.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. MediPharm Labs Corp. published the original content used to generate this news brief via PR Newswire (Ref. ID: NY92385) on May 20, 2025, and is solely responsible for the information contained therein.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10